|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 3:692-703, 2004.
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc.
Ligand-binding Domain*
,



,**,

From the
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17177 Stockholm, Sweden;
Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden; ¶ Department of Clinical Chemistry, Karolinska Hospital, SE-17177 Stockholm, Sweden; || GlaxoSmithKline, Discovery Research, Research Triangle Park, NC 27709; and ** Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, London WC1N 1AX, United Kingdom
Nuclear receptors (NRs) constitute a large and highly conserved family of ligand-activated transcription factors that regulate diverse biological processes such as development, metabolism, and reproduction. As such, NRs have become important drug targets, and the identification of novel NR ligands is a subject of much interest. The retinoid X receptor (RXR) belongs to a subfamily of NRs that bind vitamin A metabolites (i.e. retinoids), including 9-cis-retinoic acid (9-cis-RA). However, although 9-cis-RA has been described as the natural ligand for RXR, its endogenous occurrence has been difficult to confirm. Recently, evidence was provided for the existence of a different natural RXR ligand in mouse brain, the highly enriched polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA) (Mata de Urquiza et al. (2000) Science 290, 21402144). However, the results suggested that supra-physiological levels of DHA were required for efficient RXR activation. Using a refined method for ligand addition to transfected cells, the current study shows that DHA is a more potent RXR ligand than previously observed, inducing robust RXR activation already at low micromolar concentrations. Furthermore, it is shown that other naturally occurring PUFAs can activate RXR with similar efficiency as DHA. In additional experiments, the binding of fatty acid ligands to RXR
is directly demonstrated by electrospray mass spectrometry of the noncovalent complex between the RXR ligand-binding domain (LBD) and its ligands. Data is presented that shows the noncovalent interaction between the RXR LBD and a number of PUFAs including DHA and arachidonic acid, corroborating the results in transfected cells. Taken together, these results show that RXR binds PUFAs in solution and that these compounds induce receptor activation, suggesting that RXR could function as a fatty acid receptor in vivo.

To whom correspondence should be addressed: Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 2939 Brunswick Square, London WC1N 1AX, United Kingdom. Tel.: 44-(0)20-7753-5876; Fax: 44-(0)20-7753-5964; E-mail: william.griffiths{at}ulsop.ac.uk
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. Zapata-Gonzalez, F. Rueda, J. Petriz, P. Domingo, F. Villarroya, J. Diaz-Delfin, M. A. de Madariaga, and J. C. Domingo Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR{gamma}:RXR heterodimers: comparison with other polyunsaturated fatty acids J. Leukoc. Biol., October 1, 2008; 84(4): 1172 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Nowickyj, J. V. Chithalen, D. Cameron, M. G. Tyshenko, M. Petkovich, G. R. Wyatt, G. Jones, and V. K. Walker Locust retinoid X receptors: 9-Cis-retinoic acid in embryos from a primitive insect PNAS, July 15, 2008; 105(28): 9540 - 9545. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Huang, V. R. King, O. E. Curran, S. C. Dyall, R. E. Ward, N. Lal, J. V. Priestley, and A. T. Michael-Titus A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury Brain, November 1, 2007; 130(11): 3004 - 3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bovet, A. Wortmann, S. Eiler, F. Granger, M. Ruff, B. Gerrits, D. Moras, and R. Zenobi Estrogen receptor-ligand complexes measured by chip-based nanoelectrospray mass spectrometry: An approach for the screening of endocrine disruptors Protein Sci., May 1, 2007; 16(5): 938 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Innis Dietary (n-3) Fatty Acids and Brain Development J. Nutr., April 1, 2007; 137(4): 855 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Folkertsma, P. I. van Noort, A. de Heer, P. Carati, R. Brandt, A. Visser, G. Vriend, and J. de Vlieg The Use of in Vitro Peptide Binding Profiles and in Silico Ligand-Receptor Interaction Profiles to Describe Ligand-Induced Conformations of the Retinoid X Receptor {alpha} Ligand-Binding Domain Mol. Endocrinol., January 1, 2007; 21(1): 30 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al. International Union of Pharmacology. LXVI. Orphan Nuclear Receptors Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Larque, S. Krauss-Etschmann, C. Campoy, D. Hartl, J. Linde, M. Klingler, H. Demmelmair, A. Cano, A. Gil, B. Bondy, et al. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 853 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Zeng, D.-F. Sun, L. Wang, X. Cao, J.-B. Qi, T. Yang, C.-Q. Hu, W. Liu, and X.-K. Zhang Hypericum sampsonii induces apoptosis and nuclear export of retinoid X receptor-alpha Carcinogenesis, October 1, 2006; 27(10): 1991 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garelli, N. P. Rotstein, and L. E. Politi Docosahexaenoic Acid Promotes Photoreceptor Differentiation without Altering Crx Expression. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3017 - 3027. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J Deckelbaum, T. S Worgall, and T. Seo n-3 Fatty acids and gene expression Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1520 - 1525S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Selvaraj and K. C. Klasing Lutein and Eicosapentaenoic Acid Interact to Modify iNOS mRNA Levels through the PPAR{gamma}/RXR Pathway in Chickens and HD11 Cell Lines J. Nutr., June 1, 2006; 136(6): 1610 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. R. Tobin, N. K. Harsem, K. T. Dalen, A. C. Staff, H. I. Nebb, and A. K. Duttaroy Regulation of ADRP expression by long-chain polyunsaturated fatty acids in BeWo cells, a human placental choriocarcinoma cell line J. Lipid Res., April 1, 2006; 47(4): 815 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hashimoto, N. Shimizu, T. Kimura, Y. Takahashi, and T. Ide Polyunsaturated Fats Attenuate the Dietary Phytol-Induced Increase in Hepatic Fatty Acid Oxidation in Mice J. Nutr., April 1, 2006; 136(4): 882 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohyama, S. Meaney, M. Heverin, L. Ekstrom, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, et al. Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1): MARKED INSENSITIVITY TOWARD DIFFERENT REGULATORY AXES J. Biol. Chem., February 17, 2006; 281(7): 3810 - 3820. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |